Cell-to-Cell Variation in Defective Virus Expression and Effects on Host Responses during Influenza Virus Infection.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
14 01 2020
Historique:
entrez: 16 1 2020
pubmed: 16 1 2020
medline: 18 9 2020
Statut: epublish

Résumé

Virus and host factors contribute to cell-to-cell variation in viral infections and determine the outcome of the overall infection. However, the extent of the variability at the single-cell level and how it impacts virus-host interactions at a system level are not well understood. To characterize the dynamics of viral transcription and host responses, we used single-cell RNA sequencing to quantify at multiple time points the host and viral transcriptomes of human A549 cells and primary bronchial epithelial cells infected with influenza A virus. We observed substantial variability in viral transcription between cells, including the accumulation of defective viral genomes (DVGs) that impact viral replication. We show (i) a correlation between DVGs and virus-induced variation of the host transcriptional program and (ii) an association between differential inductions of innate immune response genes and attenuated viral transcription in subpopulations of cells. These observations at the single-cell level improve our understanding of the complex virus-host interplay during influenza virus infection.

Identifiants

pubmed: 31937643
pii: mBio.02880-19
doi: 10.1128/mBio.02880-19
pmc: PMC6960286
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : S10 OD018522
Pays : United States
Organisme : NIH HHS
ID : S10 OD026880
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI111598
Pays : United States

Informations de copyright

Copyright © 2020 Wang et al.

Références

Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Elife. 2019 May 15;8:
pubmed: 31090537
J Biol Chem. 2010 Feb 26;285(9):6080-90
pubmed: 20048147
PLoS Pathog. 2017 Oct 12;13(10):e1006650
pubmed: 29023600
Vaccine. 2011 Mar 24;29(15):2777-84
pubmed: 21320545
PLoS One. 2012;7(12):e49394
pubmed: 23251341
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16303-8
pubmed: 20805493
J Interferon Cytokine Res. 2013 Mar;33(3):99-107
pubmed: 23215782
Appl Microbiol Biotechnol. 2014 Nov;98(21):8999-9008
pubmed: 25132064
Vaccine. 2013 Nov 19;31(48):5713-21
pubmed: 24099876
Future Virol. 2018 Jul;13(7):493-503
pubmed: 30245734
J Biol Chem. 2010 Dec 31;285(53):42013-22
pubmed: 20943654
Rev Med Virol. 2010 Jan;20(1):51-62
pubmed: 20041441
J Gen Virol. 2011 Dec;92(Pt 12):2879-88
pubmed: 21880840
Nat Commun. 2015 Nov 20;6:8938
pubmed: 26586423
J Virol. 2007 Nov;81(22):12227-37
pubmed: 17804509
mBio. 2015 Oct 06;6(5):e01265-15
pubmed: 26443454
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
EMBO J. 2013 Oct 16;32(20):2751-63
pubmed: 24065129
Nat Microbiol. 2018 Nov;3(11):1234-1242
pubmed: 30224800
PLoS Comput Biol. 2015 Nov 30;11(11):e1004574
pubmed: 26618778
Curr Top Microbiol Immunol. 1985;114:103-51
pubmed: 3888540
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Genome Biol. 2014;15(12):550
pubmed: 25516281
Curr Opin Virol. 2017 Apr;23:82-87
pubmed: 28456056
Cell Syst. 2018 Jun 27;6(6):679-691.e4
pubmed: 29886109
Nucleic Acids Res. 2013 May 1;41(10):e108
pubmed: 23558742
J Virol. 2009 Oct;83(19):10309-13
pubmed: 19605485
J Gen Virol. 2017 Mar;98(3):357-363
pubmed: 27983470
J Virol. 2019 Mar 5;93(6):
pubmed: 30626670
Bioinformatics. 2013 Feb 15;29(4):461-7
pubmed: 23267174
J Virol. 1983 Jan;45(1):55-61
pubmed: 6185696
J Virol. 2017 Oct 27;91(22):
pubmed: 28855247
Elife. 2018 Feb 16;7:
pubmed: 29451494
Virology. 2006 Jul 20;351(1):101-11
pubmed: 16631220
Cell Rep. 2017 Jul 5;20(1):251-263
pubmed: 28683318
Science. 1943 Jul 23;98(2534):87-9
pubmed: 17749157
Oncoimmunology. 2012 Nov 1;1(8):1376-1386
pubmed: 23243601
J Virol. 2013 Jul;87(14):8064-74
pubmed: 23678180
Nat Commun. 2017 Oct 6;8(1):799
pubmed: 28986577
J Gen Virol. 1980 Sep;50(1):23-31
pubmed: 7441212
J Virol. 2019 Feb 5;93(4):
pubmed: 30463965
Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):9610-9615
pubmed: 30181264
J Virol. 2013 Mar;87(6):3155-62
pubmed: 23283949
Curr Opin Virol. 2018 Dec;33:74-80
pubmed: 30099321
J Virol. 2019 May 15;93(11):
pubmed: 30867305
J Biol Chem. 2008 Nov 7;283(45):31183-96
pubmed: 18772142
Virology. 1979 May;95(1):48-58
pubmed: 442544
Genes Immun. 2011 Sep;12(6):399-414
pubmed: 21490621
Cell. 1981 Oct;26(2 Pt 2):145-54
pubmed: 7037195
Antiviral Res. 2012 Dec;96(3):376-85
pubmed: 23041142
Cell Host Microbe. 2017 Dec 13;22(6):789-800.e5
pubmed: 29241042
J Virol. 2002 Jun;76(11):5532-9
pubmed: 11991981
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Vaccine. 2010 Nov 23;28(50):8015-25
pubmed: 20934458
Proc Natl Acad Sci U S A. 1979 Jul;76(7):3092-6
pubmed: 290988
J Virol. 2014 May;88(10):5217-27
pubmed: 24574404
Vaccine. 2011 Sep 2;29(38):6584-91
pubmed: 21762748
Genome Res. 2015 Dec;25(12):1860-72
pubmed: 26430063
Virology. 2009 Mar 1;385(1):39-46
pubmed: 19070881
Virology. 2010 Nov 25;407(2):247-55
pubmed: 20833406
Annu Rev Virol. 2019 Sep 29;6(1):547-566
pubmed: 31082310
Virology. 1955 May;1(1):128-39
pubmed: 13267981
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
J Virol. 2019 Sep 30;93(20):
pubmed: 31375585
Cell. 2008 Oct 17;135(2):216-26
pubmed: 18957198
J Leukoc Biol. 2015 Jul;98(1):119-28
pubmed: 25896227
Elife. 2018 Feb 16;7:
pubmed: 29451492
J Virol. 2019 Jun 28;93(14):
pubmed: 31068418
J Virol. 1983 Feb;45(2):659-64
pubmed: 6300428
J Virol. 2014 May;88(9):4632-46
pubmed: 24574395
Nat Commun. 2013;4:1591
pubmed: 23481399
Methods Mol Biol. 2012;865:175-92
pubmed: 22528160
J Virol. 2008 Sep;82(17):8570-8
pubmed: 18579602
Cell. 1983 Sep;34(2):619-27
pubmed: 6616623
J Virol. 2014 Aug;88(16):8720-3
pubmed: 24872580
PLoS Pathog. 2013 Oct;9(10):e1003703
pubmed: 24204261
Adv Virus Res. 1954;2:59-79
pubmed: 13228257
Genome Biol. 2015 Dec 10;16:278
pubmed: 26653891
J Virol. 2010 Dec;84(24):12832-40
pubmed: 20861262
Nat Rev Immunol. 2014 May;14(5):315-28
pubmed: 24762827
Curr Opin Virol. 2018 Apr;29:39-50
pubmed: 29558678
Virology. 2012 Mar 1;424(1):11-7
pubmed: 22222212
Virus Res. 2015 Nov 2;209:11-22
pubmed: 25678267
Proc Natl Acad Sci U S A. 1980 Jan;77(1):215-9
pubmed: 6928614
Cell Rep. 2017 Nov 7;21(6):1692-1704
pubmed: 29117571
Nat Commun. 2018 Nov 28;9(1):5037
pubmed: 30487586
Elife. 2016 Aug 15;5:
pubmed: 27525483
Nat Microbiol. 2019 Jul;4(7):1075-1087
pubmed: 31160826
PLoS Pathog. 2015 May 29;11(5):e1004924
pubmed: 26024522
J Virol. 2013 Mar;87(6):3039-52
pubmed: 23283961
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12363-E12369
pubmed: 30530648
Nat Biotechnol. 2015 May;33(5):495-502
pubmed: 25867923

Auteurs

Chang Wang (C)

Center for Genomics and Systems Biology, Department of Biology, New York University, New York, New York, USA.

Christian V Forst (CV)

Mount Sinai Center for Transformative Disease Modeling, Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Tsui-Wen Chou (TW)

Center for Genomics and Systems Biology, Department of Biology, New York University, New York, New York, USA.

Adam Geber (A)

Center for Genomics and Systems Biology, Department of Biology, New York University, New York, New York, USA.

Minghui Wang (M)

Mount Sinai Center for Transformative Disease Modeling, Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Wissam Hamou (W)

Mount Sinai Center for Transformative Disease Modeling, Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Melissa Smith (M)

Mount Sinai Center for Transformative Disease Modeling, Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Robert Sebra (R)

Mount Sinai Center for Transformative Disease Modeling, Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Bin Zhang (B)

Mount Sinai Center for Transformative Disease Modeling, Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Bin Zhou (B)

Center for Genomics and Systems Biology, Department of Biology, New York University, New York, New York, USA.

Elodie Ghedin (E)

Center for Genomics and Systems Biology, Department of Biology, New York University, New York, New York, USA elodie.ghedin@nyu.edu.
College of Global Public Health, New York University, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH